Recognize the pattern
Restless legs syndrome commonly involves an urge to move, often with uncomfortable leg sensations. Symptoms emerge or worsen during rest, improve at least temporarily with movement, and are more prominent in the evening or night. The whole pattern matters more than one descriptive word such as crawling or aching.
Cramps, neuropathy, positional discomfort, and other problems can resemble parts of this history. A clinician considers whether another condition explains the symptoms. A person should not assume every bedtime leg ache is RLS.
RLS and periodic limb movements are not the same
RLS symptoms are generally described while awake and resting. Periodic limb movements occur during sleep and can be recorded in testing. Many people with RLS have movements, but movements alone do not establish RLS or a separate movement disorder.
A partner noticing kicking is useful information, not a diagnosis. Report daytime effects, frequency, symptom timing, and relief with movement. Clinical interpretation prevents unnecessary treatment of an isolated wearable movement estimate.
What assessment should review
Discuss family history, pregnancy, kidney disease, relevant neurological symptoms, sleep opportunity, and medicines. Antihistaminergic, serotonergic, and antidopaminergic medicines can worsen symptoms in some people. Alcohol, caffeine, and untreated obstructive apnea may also be relevant.
Do not abruptly stop an antidepressant, anti-nausea medicine, or other prescription after reading a trigger list. Ask the prescriber or pharmacist whether the exact drug, dose, indication, and alternatives matter in your case. A medicine review balances more than the leg symptom alone.
Why iron testing matters
The 2025 AASM guideline emphasizes regular iron studies in clinically significant RLS, including ferritin and transferrin saturation. Treatment decisions use RLS-specific clinical guidance and are not identical to interpreting a routine anemia screen.
This guide deliberately avoids a personal supplement dose or laboratory cutoff as a self-treatment rule. Oral versus intravenous iron, eligibility, monitoring, and adverse effects depend on results and circumstances. Excess iron can be harmful; more is not automatically better. Bring existing results to the clinician.
Evidence: [2]
Updated treatment priorities
The updated AASM guideline supports selected alpha-2-delta ligand medicines and specific iron approaches for appropriate patients. Other options are reserved for particular circumstances. Choice depends on benefits, sedation, other conditions, and follow-up.
An important shift concerns routine dopamine-related treatment because of augmentation risk. A drug that helped initially can later worsen the pattern. Older lists that present every commonly used medicine as equally preferred miss this change. Do not interpret a recommendation as a prescription for yourself.
Evidence: [2]
Recognize augmentation and avoid abrupt changes
Augmentation is treatment-related worsening that can include symptoms starting earlier, appearing after shorter rest, becoming more intense, or spreading beyond the original pattern. It is different from simply having one difficult evening.
If you are taking a dopamine-related drug and notice these changes, contact the treating clinician. Do not abruptly discontinue it or repeatedly increase the dose on your own. Transition planning can be complex, and a supervised approach addresses rebound and other risks.
Evidence: [2]
Practical supports and questions for follow-up
Regular sleep opportunity and moderate activity can be useful background habits. Some people find temporary comfort from movement, massage, or a warm bath; these do not establish treatment of the underlying condition. Adapt heat and movement to comfort and safety.
Keep a brief log of onset time, time at rest before symptoms, relief with movement, medicines, and daytime impact. Ask whether the diagnosis fits, whether iron studies are appropriate, whether a drug may be worsening the pattern, and how improvement will be measured. Pregnancy and kidney disease need specific care.
Frequently asked questions
Can I take iron without testing?
Do not self-dose iron for suspected RLS. A clinician should review iron studies, suitability, route, and monitoring.
Is leg kicking during sleep the same as RLS?
No. Periodic limb movements and the waking urge-to-move syndrome are related but distinct.
What if my medicine helped before but symptoms now begin earlier?
Contact the prescriber to assess augmentation or other causes. Do not abruptly stop or increase treatment yourself.
Sources and editorial limits
This is a focused review of selected authoritative guidance, systematic reviews, and relevant trials, not an exhaustive systematic review. Publication dates, evidence-search dates, and the editorial update date are different. No commercial product has been clinically tested by our editorial team.